(Q40715769)
Statements
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma (English)
G K Schwartz
D Ilson
L Saltz
W Tong
J Werner
P Perkins
M Stoltz
scientific article published on April 2001
No description defined